- Release Date: 29/11/21 08:15
- Summary: VGI Health Technology partners with ENDRA Life Sciences in NAFLD/NASH Phase II Clinical Study (Price Sensitive)
- Price Sensitive: Yes
- Download Document 103.89KB
- Forums
- NSX - By Stock
- Ann:VGI Health Technology partners with ENDRA Life Sciences in NAFLD/NASH Phase II Clinical Study...
Ann:VGI Health Technology partners with ENDRA Life Sciences in...
Featured News
Featured News
The Watchlist
3DA
AMAERO LTD
Hank Holland, Chairman and CEO
Hank Holland
Chairman and CEO
Previous Video
Next Video
SPONSORED BY The Market Online